Financhill
Back

Ultragenyx Pharmaceutical Stock Predictions

Ultragenyx Pharmaceutical Stock Forecast

  • Is Ultragenyx Pharmaceutical Stock Undervalued?
    The current Ultragenyx Pharmaceutical [RARE] share price is $54.43. The Score for RARE is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
  • RARE is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.

Will Ultragenyx Pharmaceutical Stock Go Up Next Year?

Data Unavailable

Ultragenyx Pharmaceutical Stock Rating

Data Unavailable

Ultragenyx Pharmaceutical Stock Price History

Is RARE stock going to rise?

  • The current trend is moderately bearish and RARE is experiencing selling pressure, which indicates risk of future bearish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
ultragenyx.com

52-Week Data

52-Week High:
60.37
52-Week Low:
31.52

Prediction Charts

Market Cap:
5.02B
Price in USD:
54.43
Volume:
575.01K
Beta:
1.10

Technical Analysis

SMA50:
52.99
SMA100:
47.11
SMA200:
46.88
52-Wk Change:
47.47%

Stock Predictions

  • Is Ultragenyx Pharmaceutical stock public?
    Yes, Ultragenyx Pharmaceutical is a publicly traded company.
  • What is the Ultragenyx Pharmaceutical stock quote today?
    The Ultragenyx Pharmaceutical stock price is 54.43 USD today.
  • How to buy Ultragenyx Pharmaceutical stock online?
    You can buy Ultragenyx Pharmaceutical shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Sep-10 55.94 55.72 56.53 55.27
Sep-11 55.53 56.31 56.54 54.94
Sep-12 56.18 57.87 57.98 56.14
Sep-13 58.00 58.74 59.76 58.00
Sep-16 59.37 59.36 60.37 58.36
Sep-17 59.32 58.49 59.56 57.83
Sep-18 58.72 57.70 58.96 57.44
Sep-19 58.54 58.77 59.90 58.21
Sep-20 58.78 58.75 59.09 57.91
Sep-23 59.17 57.56 59.50 57.42
Sep-24 57.52 57.44 58.14 56.38
Sep-25 57.60 56.76 57.78 56.74
Sep-26 56.99 55.20 57.13 55.13
Sep-27 55.44 54.43 55.44 54.29

Ultragenyx Pharmaceutical Earnings

Data Unavailable

Ultragenyx Pharmaceutical Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings increase this quarter of $0.53 per share, an increase next quarter of $0.18 per share, an increase this year of $1.07 per share, and an increase next year of $1.02 per share.

* Ultragenyx Pharmaceutical stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.